News
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60.
5d
MedPage Today on MSNCDC Follows Advice of Ousted Vaccine Panel, Expands Access to RSV ShotWith the CDC director's chair still empty, HHS Secretary Robert F. Kennedy Jr. endorsed recommendations made months ago by ...
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...
The U.S. CDC recommends RSV vaccines for high-risk adults aged 50-59, endorsing the views of the former vaccine advisory ...
The CDC says that, yearly, RSV leads to 58,000–80,000 hospitalizations among children younger than 5 years old and 100,000–150,000 hospitalizations among adults 60 years and older.
Hosted on MSN11mon
RSV vaccine market to decline 64% on CDC decision: report - MSNThe updates prompted London-based Airfinity to cut its forecast for the U.S. RSV vaccine market by 64% to $1.7B from $4.7B a year to reflect the revised guidance, which, it said, reduced the ...
Hosted on MSN11mon
You may want to skip fall RSV vaccine, CDC says. What to know about new recommendations - MSNStudies presented to the CDC ACIP Work Group for RSV found both vaccines from fall 2023 may result in a slightly elevated risk of Guillain-Barré syndrome, a rare but serious condition.
When you buy through links on our articles, Future and its syndication partners may earn a commission. Adults ages 75 and older should get a single dose of an RSV vaccine, the CDC says. Younger ...
ALBUQUERQUE, N.M. – If you haven’t gotten sick yet, chances are you know someone who has. According to the latest data from the CDC, New Mexico is one of more than 20 states in the “very ...
RSV sent fewer babies to the hospital last winter, after new treatment and vaccine arrived New tools may have reduced cases of severe respiratory illness, CDC says Manage alerts for this article ...
Hosted on MSN9mon
GSK, Pfizer seeing drop in demand for RSV vaccines: report - MSNIn the prior vaccination season, the CDC had recommended the shot for most people aged 60 or older, Reuters said. Pfizer ( PFE ) declined to comment on the matter, Reuters added. More on GSK ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results